{
    "code": "06017316",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06017316",
    "time": "2021-10-22 07:13:25",
    "許可證字號": "衛署醫器輸字第017316號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/09\/13",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "QSD4031",
    "有效日期": "110\/09\/07",
    "發證日期": "95\/09\/07",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00601731602",
    "中文品名": "貝克曼庫爾特協康新苯二氮試劑",
    "英文品名": "BECKMAN COULTER SYNCHRON Benzodiazepine (BNZG) Reagent",
    "效能": "新苯二氮(Benzodiazepine；BNZG)試劑測試是結合使用協康系統藥物濫用測試尿液校正液(Drugs of Abuse Testing，DAT)，利用SYNCHRON System的生化儀器，在Cutoff值在200ng\/mL的情況下，定性人類尿液中的苯二氮。",
    "醫器規格": "A18298: 1 x 250 tests\/kit",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A3170苯(并)二氮試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "6201027023  美商貝克曼庫爾特有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路二段216號8樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060173160001-102-10-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06017316&Seq=001&Type=9"
        }
    ]
}